Active, Not Recruiting
Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid Cancer
NCT04061980
- Conditions
- BRAF NP_004324.2:p.V600M, BRAF V600E Mutation Present, Endocrine Gland Neoplasms, +11 more
- Locations
-
- Providence Portland Medical Center Portland, Oregon, United States